DEKRA Accredited To Audit Against UKCA Marking, But More UK Capacity Needed
First post-Brexit UK approved body receives designation
A fourth approved body has been accredited to audit medical device submissions against the UKCA marking. A fifth is thought to be not far behind, but current assumptions are that overall auditing capacity will not be adequate under the forthcoming UK medical device regulations.
You may also be interested in...
The spotlight is on IVDs in the post-COVID phase. Innovators in university spin-outs and the established industry have responded with new technologies, creating a vibrant scene. Regulators and reimbursors must not disrupt the momentum, say BIVDA’s regulatory affairs manager Ashleigh Batchen and chief executive Doris-Ann Williams.
The UK’s new medical device regulations remain a work in progress, ahead of the parliamentary process and codification into law in 2023. The ABHI’s Phil Brown says industry will continue to advise the government on how to maximize fully the rare opportunity the UK stands before.
3M’s health care company spin-off is expected to be launched in the first half of 2024 under the name Solventum.